ID: ALA4248415

Max Phase: Preclinical

Molecular Formula: C29H35ClN4O6SSi

Molecular Weight: 631.23

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCOc1cc(Cl)c(C(=O)NC(=O)Nc2nc3c(s2)C[Si](C)(c2c(OC)cccc2OC)CC3)cc1N1CCOCC1

Standard InChI:  InChI=1S/C29H35ClN4O6SSi/c1-5-40-24-16-19(30)18(15-21(24)34-10-12-39-13-11-34)27(35)32-28(36)33-29-31-20-9-14-42(4,17-25(20)41-29)26-22(37-2)7-6-8-23(26)38-3/h6-8,15-16H,5,9-14,17H2,1-4H3,(H2,31,32,33,35,36)

Standard InChI Key:  KLYHSXJWJKESMD-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 631.23

Molecular Weight (Monoisotopic): 630.1735

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Ramesh R, Reddy DS..  (2018)  Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.,  61  (9): [PMID:29039662] [10.1021/acs.jmedchem.7b00718]

Source

Source(1):

• Scientific Literature